| Madagascar | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 124.3 (2020) [134/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 4.9 (2020) [78/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.3 (2020) [144/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 34.7 (2020) [131/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 41.2 (2020) [13/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 3.3 (2020) [160/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 2.1 (2020) [166/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.2 (2020) [156/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.2 (2020) [146/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 0.7 (2020) [156/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 3.5 (2020) [131/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 2.6 (2020) [74/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 6.0 (2020) [78/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 2.5 (2020) [168/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 4.7 (2020) [83/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 0.4 (2020) [159/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.5 (2020) [79/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 6.1 (2020) [100/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 4.9 (2020) [33/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 1.3 (2020) [48/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 2.8 (2020) [174/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 1.7 (2020) [146/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 31.5 (2020) [114/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 4.9 (2020) [112/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.3 (2020) [148/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 1.0 (2020) [158/184countries] | | |
|
| Madagascar | | |
Suicide, age-standardized (per 100 000 population) | 9.18 (2019) [85/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 13.33 (2019) [93/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 5.42 (2019) [59/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 3.43 (2019) [138/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 4.92 (2019) [139/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.95 (2019) [122/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 4.76 (2019) [143/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 6.85 (2019) [148/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 2.68 (2019) [108/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 6.45 (2019) [130/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 9.01 (2019) [137/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 3.90 (2019) [89/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 13.49 (2019) [85/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 18.91 (2019) [93/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 8.26 (2019) [53/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 21.70 (2019) [57/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 30.15 (2019) [65/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 13.92 (2019) [33/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 33.38 (2019) [41/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 49.41 (2019) [49/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 19.51 (2019) [30/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 48.38 (2019) [41/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 76.80 (2019) [42/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 25.90 (2019) [38/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 100.90 (2019) [44/183countries] | | |
|
|